Electronic Information and Digital Industry

In 2020, output of industrial companies with annual revenue of more than RMB 20 million expanded by 6.6 percent year-on-year, exceeding RMB 800 billion. Xiamen City and Fuzhou City are the main production bases for computers and new displays in the province. Fujian has become one of the main production bases of terminal products such as flat panel displays, laptops, and LCD TVs in China, and one of China’s strongest and largest production bases for LED epitaxial wafers with the most complete varieties.

Advanced Equipment Manufacturing Industry

In 2020, the output of industrial companies with annual revenue of more than RMB 20 million increased by 1.1 percent year on year, exceeding RMB 870 billion. The production and sale of loaders, medium and large-sized buses, automobile steel wheels, joint bearings, road rollers, and small and medium-sized electrical machinery are at the forefront of advanced equipment manufacturing growth in China.

New Energy Industry

In 2020, industrial enterprises with annual revenue of more than RMB 20 million increased their added value by 9.7 percent year on year with an output value of over RMB 140 billion. Leading enterprises such as JP Solar Power (Fujian) Company Limited and Gold Stone (Fujian) Energy Company Limited have been set up in the photovoltaic industry, with accelerated efforts to build a leading heterojunction battery production base in China. The installed capacity of the Lithium-ion power battery of Contemporary Amperex Technology Co., Ltd. (CATL) ranks first in the world.

Biological & New Pharmaceutical Industry

In 2020, the added value of industrial enterprises above designated size rose by 0.3 percent year on year, and the output value of the industry exceeded RMB 60 billion. The technology of such protein drugs as recombinant human granulocyte-macrophage colony-stimulating factor and its market share took the lead in China. In addition, bio-pharmaceutical technologies such as an Escherichia coli-derived virus-like particle-based vaccine, a recombinant hepatitis E vaccine, and a recombinant human papillomavirus vaccine all held world leading positions.